구조적 심질환 기기 시장 규모, 점유율, 성장 분석 : 제품별, 시술별, 지역별 - 업계 예측(2026-2033년)

Global Structural Heart Devices Market size was valued at USD 15.5 Billion in 2024 and is poised to grow from USD 17.07 Billion in 2025 to USD 36.85 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The global structural heart devices market is experiencing significant growth driven by the high prevalence of systemic heart diseases, affecting approximately 60 million individuals in the U.S., representing 20-25% of the adult population. This highlights the crucial role of these devices in addressing cardiac defects. Treatments encompass a variety of percutaneous therapies aimed at managing both acquired and congenital heart conditions. As healthcare costs for procedures like Transcatheter Aortic Valve Replacement (TAVR) are projected to improve, affordability will rise, encouraging adoption, particularly as the aging population seeks care covered by Medicare and Medicaid services. Increased investment in research and development by industry leaders fuels innovation, further enhancing product offerings and competition within the structural heart devices market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Structural Heart Devices Market Segments Analysis

Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Structural Heart Devices Market

The Global Structural Heart Devices market is experiencing significant growth driven by the rising prevalence of heart failure, largely attributed to an aging population, inactive lifestyles, and unhealthy dietary habits. These trends are resulting in a heightened need for various cardiac devices, especially as conditions like aortic stenosis, mitral regurgitation, and congenital heart defects are increasingly diagnosed among older individuals. Moreover, the demand for sophisticated advancements in cardiac mechanical engineering is expected to continue, with a particular focus on innovative transcatheter interventions, including vein treatments and occluders, further propelling the market forward as healthcare professionals seek effective solutions for these complex heart conditions.

Restraints in the Global Structural Heart Devices Market

The Global Structural Heart Devices market faces significant challenges due to the high costs associated with these advanced medical technologies and their minimally invasive procedures. In regions where healthcare support is limited, the expense of both the devices and the associated treatments can restrict access for many patients, particularly those in low- to middle-income brackets. This financial barrier can hinder market growth and adoption rates, as individuals may struggle to afford the necessary care. Moreover, reimbursement issues in certain areas further exacerbate the situation, dissuading patients from seeking treatment and impeding overall market progress.

Market Trends of the Global Structural Heart Devices Market

The Global Structural Heart Devices market is experiencing a significant shift driven by the growing adoption of Transcatheter Aortic Valve Replacement (TAVR) systems, which are increasingly favored for treating severe aortic stenosis, particularly among patients deemed unsuitable for conventional surgical interventions. The minimally invasive nature of TAVR procedures has garnered positive clinical outcomes, prompting heightened demand for these advanced devices. In response, manufacturers are making substantial investments in the development of next-generation TAVR systems, aiming to broaden patient eligibility and enhance treatment efficacy. This trend not only signifies an evolving approach to managing structural heart conditions but also indicates a robust growth trajectory for the market overall.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Structural Heart Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Market Overview
• Heart Valve Devices
  • Transcatheter Heart Valves
  • Surgical Heart Valves
  • Tissue Heart Valves
  • Mechanical Heart Valves
• Occluders & Delivery Systems
• Annuloplasty Rings
• Accessories
• Other Devices

Global Structural Heart Devices Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Replacement Procedures
  • TAVR Procedures
  • SAVR Procedures
• Repair Procedures
  • Closure Procedures
  • Annuloplasty
  • Valvuloplasty

Global Structural Heart Devices Market Size & CAGR (2026-2033)

• North America (Product, Procedure)
  • US
  • Canada
• Europe (Product, Procedure)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Comed BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioKinetix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations